We were magnet fishing, hoping for something cool maybe a safe, maybe a scooter. Instead, we found something that looks suspiciously like evidence. The police were called. They were… not thrilled.

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...

Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors Solve ...

New issue New issue Open Open [Improvement] In CatalogOperations.java fix exception #9081 Assignees Labels good first issueGood for newcomersimprovementImprovements on everything ...

I'm the Founder and Publisher of Potomac Local News. Raised in Woodbridge, I'm now raising my family in Northern Virginia and care deeply about our community. If you're not getting our FREE email ...

Researchers at the University at Buffalo have advanced a powerful yet affordable quantum modeling method known as the truncated Wigner approximation. Their improved version can now solve complex, real ...

A group of Harvard faculty members say many students at the Ivy League university are skipping class, skimming or ignoring reading assignments, avoiding challenging discussions, and still graduating ...

When the Milwaukee School Board approved a class size policy in 1995, it was with the intention to continue lowering class sizes in future years. Thirty years later, the school district is operating ...

Sarah Lenhoff receives funding from the Skillman Foundation, the Joyce Foundation, the Kresge Foundation, the William T. Grant Foundation, the American Institutes for Research, and the Urban Institute ...

A new report shows there is absolutely a winning constituency for economic and social progress. But Democrats aren’t pursuing it. Ad Policy Senator Bernie Sanders (I-VT) speaks to a full auditorium as ...